Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus

Lasers in Surgery and Medicine

Volumn 24, Issue 1, 1999, Pages 3-13

  Van Den Boogert, Jolanda ^a   Houtsmuller, Adriaan B ^a   De Rooij, Felix W M ^a   De Bruin, Ron W F ^a   Siersema, Peter D ^a   Van Hillegersberg, Richard ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ferrochelatase; Fluorescence; Iron; Photodynamic therapy; Porphobilinogen deaminase

Indexed keywords

AMINOLEVULINIC ACID; FERROCHELATASE; IRON; PHOTOSENSITIZING AGENT; PORPHOBILINOGEN DEAMINASE; PORPHYRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS MUCOSA; ESOPHAGUS MUSCLE; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; LASER MICROSCOPY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ADMINISTRATION, ORAL; AMINOLEVULINIC ACID; ANIMALS; BARRETT ESOPHAGUS; DISEASE MODELS, ANIMAL; ESOPHAGUS; FLUORESCENCE; INJECTIONS, INTRAVENOUS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; REFERENCE VALUES;

EID: 0032960423     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1999)24:1<3::AID-LSM3>3.0.CO;2-N     Document Type: Article

References (34)

1. Blot WJ, Devesa SS, Kneller, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-1289.
2. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313:857-859.
3. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990; 35:93-96.
4. Sampliner RE, Hixson LJ, Fennerty B, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993; 38:365-368.
5. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993; 104:1686-1691.
6. Overholt BF, Panjehpour M. Photodynamic therapy eliminates dysplasia in Barrett's esophagus. Gastroenterology 1997; 112:A634.
7. Wang KK, Wong Kee Song LM, Nourbakhsh A, Balm R. Can consistent tissue necrosis be achieved during photodynamic therapy for high-grade dysplasia or cancer within Barrett's esophagus? Gastroenterology 1997; 112:A676.
8. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving Photophrin. Lasers Surg Med 1990; 10:485-488.
9. 14C]-hematoporphyrin derivative in malignant and normal tissue. Cancer Res 1979; 39:146-151.
10. Tralau CJ, Barr H, MacRobert AJ, Bown SG. Relative merits of porphyrins and phtalocyanine sensitization for photodynamic therapy. In: Kessel D, ed. "Photodynamic Therapy of Neoplastic Disease." Boca Raton, FL: CRC Press, 1990, pp 263-275.
11. Van Hillegersberg R, Van den Berg JWO, Kort WJ, Terpstra OT, Wilson JHP. 5-Aminolevulinic acid-induced endogenous photosensitization. Gastroenterology 1992; 103:647-651.
12. Van Hillegersberg R, Kort WJ, Wilson JHP. Current status of photodynamic therapy in oncology. Drugs 1994; 48:510-527.
13. Kennedy JC, Pettier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B Biol 1992; 14:275-292.
14. Lauka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995; 42:59-63.
15. Overholt BF, Panjehpour M. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc 1995; 42:64-69.
16. Gossner L, Sroka R, May A, Rick K, Hahn EG, Ell C. Photodynamic ablation of severe dysplasia and mucosal cancer in Barrett's esophagus using 5-ALA. Gastrointest Endosc 1997; 45:AB69.
17. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348:584-585.
18. Levrat M, Lambert R, Kirhbaum G. Esophagitis produced by reflux of duodenal contents in rats. Am J Dig Dis 1962; 7:564-573.
19. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I, Hattori T. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996; 67:269-274.
20. Van den Boogert J, Van Hillegersberg R, de Rooij FWM, De Bruin RWF, Edixhoven-Bosdijk A, Houtsmuller AB, Siersema PD, Wilson JHP, Tilanus HW. 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B Biol 1998; 44:29-38.
21. De Rooij FWM, Hamer CM, Wilson JHP. Purification of porphobilinogen deaminase from human erythrocytes by fast protein liquid chromatography. Clin Chim Acta 1987; 162:61-68.
22. Chisolm J, Brown DH. Micro-scale photofluoremetric determination of "free erythro cyte porphyrin" (protoporphyrin IX). Clin Chem 1975; 21:1669-1682.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
24. Wilson JHP, De Rooij FWM, Te Velde K. Acute intermittent porphyria in the Netherlands: heterogeneity of the enzyme porphobilinogen deaminase. Netherl J Med 1986; 29:393-399.
25. Li F, Lim CK, Peters TJ. An HPLC assay for rat liver ferrochelatase activity. Biomed Chromatogr 1987; 2:164-168.
26. Lauber K. Determination of serum iron; a comparison of two methods: teepol/dithionite/bathophenan-throlin versus guanidine/ascorbic acid/ferrozine. J Clin Chem Clin Biochem 1980; 18:147-148.
27. Ackroyd R, Roberts DJH, Vernon DI, Brown NJ, Reed MWR. Photodynamic therapy for Barrett's oesophagus: a dosimetric pilot study. Br J Surg 1996; 83:1637.
28. Mäkinen K, Grönlund-Pakkanen S, Tiirikainen M, Nuutinen P, Kuusisto A, Alhava E. Protoporphyrin-IX distribution and photodynamic effect in rat oesophagus after aminolaevulinic acid administration. Scand J Gastroenterol 1997; 32:633-637.
29. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79:2282-2308.
30. Rasseti L, Rubino GF, Drago W. Ferrochelatase, ALA-dehydrogenase and ALA-synthetase activity in human tumour tissue. Panminerva Med 1967; 8:132-135.
31. Siersema PD, Wilson JHP, Edixhoven-Bosdijk A, De Rooij FWM, Tilanus HW. Increased porphobilinogen deaminase activity in pre- and malignant tissue of the esophagus. Gastrointest Oncol 1995; 41:A537.
32. Linuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer 1994; 70:21-28.
33. Chang SC, MacRobert AJ, Porter JB, Bown SG. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolevulinic acid administration: an in vivo study. J Photochem Photobiol B Biol 1997; 38:114-122.
34. Ward CG, Bullen JJ, Rogers HJ. Iron and infection: new developments and their implications. J Trauma 1996; 41: 356-364.